Skip to content
★ Sign in to follow
Kidswell Bio Corporation logo

Kidswell Bio Corporation Stock: price and insider trades · Japan

キッズウェル・バイオ株式会社

JP·Mcap JP¥7.5BHealth Care

Kidswell Bio Corporation: what insiders have been doing

Kidswell Bio Corporation is a Health Care company. Its directors and officers file their transactions with EDINET (Japan FSA). 2 insiders have disclosed 2 filings since 26 October 2025.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Compared with its exchange (3,205 companies, median 3 filings), a count of 2 filings is below the norm. Since 2022, the database holds no purchases and 20 sales by insiders of the company.

Insider buying of Kidswell Bio Corporation has been absent for the past year.

Every figure here comes from the filings published by EDINET (Japan FSA) and describes the past, not future prices; it is not investment advice.

Insider Decl.
58
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€578,344
20 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,740 of 26,897 companies
19.5
score / 100
Value
16
Quality
23
FCF yld-16%
Earn yld-6.1%
EV/EBITDA·
ROE-19%
Gross mgn27%
Net mgn-6.3%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥151
Analyst consensus
1 analysts
·
JP¥450Target JP¥450(+198%)JP¥450
Income statement
RevenueJP¥6.6B
Gross profitJP¥1.7B27% margin
EBITDA-JP¥353.6M-5% margin
Net income-JP¥414M-6.1% margin
Valuation
PER (trailing)26.4x
P/Book4.1x
Beta1.12
Balance sheet & cash
Market capJP¥7.5B
Total debtJP¥2.6B
Free Cash Flow-JP¥1.1B
Debt / Equity135%
Profitability & ownership
ROE-19.2%
ROA-1.1%
% insiders28.3%
% institutions2.9%
Last declaration on 29 July 2026
Declarations58 total

25 of 58 declarations

About Kidswell Bio Corporation

Kidswell Bio Co., Ltd. is a company focused on the health and pharmaceutical sector. It is listed on the XTKS market.